Degrees Pharmaceuticals (SXTP) announced the name of its chronic babesiosis trial is the B-FREE Chronic Babesiosis Study. The B-FREE study, the ...
Budderfly’s virtual power plants, piloted in 2024 and launched officially in 2025, let small-to-midsize businesses install ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback